![]() 1,018,074,981 visitors served. |
|
![]() Dictionary/ thesaurus | ![]() Medical dictionary | ![]() Legal dictionary | ![]() Financial dictionary | ![]() Acronyms | ![]() Idioms | ![]() Encyclopedia | ![]() Wikipedia encyclopedia | ? |
ALS/MND |
0.01 sec. |
|
|
? References in periodicals archive |
|---|
The findings will be presented on Thursday, November 30 at the 17th
International Symposium on ALS/MND in Yokohama, Japan. will be presenting previously-released data from the
Company's Phase IIa trial with its lead small molecule product
candidate arimoclomol for the treatment for amyotrophic lateral
sclerosis (ALS or Lou Gehrig's disease) at the 17th International
Symposium on ALS/MND being held November 30 through December 2, 2006 in
Yokohama, Japan. Donoghue, who is also Professor and Chairman of the Department
of Neuroscience at Brown University, addressed leading international
researchers, as well as health and social care professionals, during
16th International Symposium on ALS/MND (amyotrophic lateral
sclerosis/motor neuron disease) on Saturday, December 10, 2005, in
Dublin, Ireland. |
| Free Tools: |
For surfers:
Browser extension |
Word of the Day |
Help
For webmasters: Free content | Linking | Lookup box | Double-click lookup | Partner with us |
|
|---|